1. Home
  2. XYLO vs ATXI Comparison

XYLO vs ATXI Comparison

Compare XYLO & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • ATXI
  • Stock Information
  • Founded
  • XYLO 1999
  • ATXI 2015
  • Country
  • XYLO Israel
  • ATXI United States
  • Employees
  • XYLO N/A
  • ATXI N/A
  • Industry
  • XYLO
  • ATXI Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYLO
  • ATXI Health Care
  • Exchange
  • XYLO NYSE
  • ATXI Nasdaq
  • Market Cap
  • XYLO 3.1M
  • ATXI 3.0M
  • IPO Year
  • XYLO N/A
  • ATXI 2017
  • Fundamental
  • Price
  • XYLO $4.73
  • ATXI $1.85
  • Analyst Decision
  • XYLO
  • ATXI
  • Analyst Count
  • XYLO 0
  • ATXI 0
  • Target Price
  • XYLO N/A
  • ATXI N/A
  • AVG Volume (30 Days)
  • XYLO 16.2K
  • ATXI 61.4K
  • Earning Date
  • XYLO 09-20-2024
  • ATXI 11-14-2024
  • Dividend Yield
  • XYLO N/A
  • ATXI N/A
  • EPS Growth
  • XYLO N/A
  • ATXI N/A
  • EPS
  • XYLO N/A
  • ATXI N/A
  • Revenue
  • XYLO $57,642,000.00
  • ATXI N/A
  • Revenue This Year
  • XYLO $16.76
  • ATXI N/A
  • Revenue Next Year
  • XYLO $5.71
  • ATXI N/A
  • P/E Ratio
  • XYLO N/A
  • ATXI N/A
  • Revenue Growth
  • XYLO N/A
  • ATXI N/A
  • 52 Week Low
  • XYLO $2.70
  • ATXI $1.60
  • 52 Week High
  • XYLO $9.07
  • ATXI $15.00
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 61.62
  • ATXI 47.67
  • Support Level
  • XYLO $4.19
  • ATXI $1.72
  • Resistance Level
  • XYLO $4.88
  • ATXI $2.04
  • Average True Range (ATR)
  • XYLO 0.49
  • ATXI 0.19
  • MACD
  • XYLO 0.04
  • ATXI -0.00
  • Stochastic Oscillator
  • XYLO 75.54
  • ATXI 33.39

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About ATXI Avenue Therapeutics Inc.

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

Share on Social Networks: